Skip to main content
Clinical Trials/JPRN-UMIN000008359
JPRN-UMIN000008359
Completed
Phase 1

Exploratory Study of Usefulness of 18F-BPA PET/CT in Clinical Staging of Malignancies - Study of Usefulness of 18F-BPA PET/CT

"Hotta Group" of National Cancer Center Cancer Research and Development Fund0 sites120 target enrollmentJuly 17, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
patients with malignancies
Sponsor
"Hotta Group" of National Cancer Center Cancer Research and Development Fund
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 17, 2012
End Date
February 1, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
"Hotta Group" of National Cancer Center Cancer Research and Development Fund

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • entered or entering to other clinical trials within 3 months Patients with uncontrollable diabetes or hypertension, with phenylketonuria, unstable angina, chronic renal disease or renal failure Patients who cannot undergo F18\-FDG PET/CT Pregnant women or women who have the possibility to be pregnant Lactating women Patient who wants the partner be pregnant Patients with mental disorders whose entry to the clinical trial seems diffucult Patients who are considered to be ineligible by referring physician

Outcomes

Primary Outcomes

Not specified

Similar Trials